Optimizing Post-Denosumab Treatment Approaches in Non-Metastatic Breast Cancer Patients Undergoing AI Therapy
Aromatase inhibitors (AIs) have solidified their position as essential agents in the adjuvant treatment landscape for hormone receptor–positive breast cancer, ...



















